New findings from a study in Kenyan adults have cast doubt on the effectiveness of the RTS,S/AS01 malaria vaccine in reducing infections among African adults, raising questions about its potential role in malaria elimination strategies.
New findings from a study in Kenyan adults have cast doubt on the effectiveness of the RTS,S/AS01 malaria vaccine in reducing infections among African adults, raising questions about its potential role in malaria elimination strategies.